Comparison of Fasting Plasma Glucose, Lipid Profile and Small Dense Low Density Lipoprotein in Severe Persistent Asthmatic and Non-Asthmatic Adults
Source : https://jbas.juw.edu.pk/index.php/JBAS/article/view/394
Haji Muhammad Rashid Department of Chemical Pathology, University of Health Sciences, Lahore, Pakistan. Nadia Aawan Department of Chemical Pathology, University of Health Sciences, Lahore, Pakistan. Hiza Hassan Department of Medical...
Conclusion: Dyslipidaemia, hyperglycaemia and elevated levels of Sd-LDL-C are associated complication of severe persistent asthma and high levels of Sd-LDL-C in severe persistent asthma are a potential risk factor to induce atherosclerosis.
Share
-
Dr Hamid4yrInteresting study as Studies of blood glucose and lipid profiles in relation to severe persistent asthma are still a few, and the results are ambiguous.
Highlights: "•Recent major clinical trials for lipid lowering therapy emphasize ‘lower the better’ concept in low density lipoprotein.•Optimal target low density lipoprotein cholesterol level is not fully investigated in Korean acute myocardial infarction•Target low density lipoprotein cholesterol levels of
Share
Shikonin Alleviates Endothelial Cell Injury Induced by ox-LDL via AMPK/Nrf2/HO-1 Signaling Pathway
Source : https://doi.org/10.1155/2021/5881321
The present study aimed to explore the effects of shikonin (SKN) on the damage of human venous endothelial cells (HUVECs) induced by ox-LDL and the underlying molecular mechanism. The HUVECs...
The level of TNF-α, IL-1β, IL-6, vascular cell adhesion molecule-1 (VCAM1), intercellular adhesion molecule-1 (ICAM1), and E-selectin (E-sel) was increased, ROS levels increased, and superoxide dismutase (SOD) level decreased. Moreover, the protein levels of p-AMPK, Nrf2, and HO-1 were decreased. Compared to the ox-LDL group, SKN treatment...
Share
Conclusion: "Our data show increased discordance between ApoB and LDL-C is associated with cardiometabolic, clinical and dietary abnormalities and that body fat percentage is causal of elevated ApoB."
Share
This chapter shows the potential of probiotic strains protecting against CVD based on clinical trials, systematic reviews, and meta-analyses. The suggested mechanisms for the hypolipidemic effects of the probiotic are also discussed.
Share